$3.50
-0.40-10.13%
最終更新: Oct 13, 2:13 PM
$3.44
-0.46-11.77%
Benzinga
Benzinga
Benzinga
火曜日, 10 13
Benzinga
© 2026 Benzinga | All Rights Reserved
bioAffinity Technologies (BIAF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
bioAffinity Technologies (BIAF) は、3 31, 2025日にfiscal yearの2025に関するガイダンスを直近で発表しました。同社は当期の売上高を$6M - $8Mの範囲と予想しています。
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-36.00 | $-40.50 | $-40.50 |
| Actual | $-9.60 | $-12.15 | $-16.65 | $-71.10 |
| Surprise | — | +66.3% | +58.9% | -75.6% |
| Revenue | ||||
| Estimate | — | $1.5M | $1.4M | $1.4M |
| Actual | $1.5M | $1.4M | $1.6M | $1.4M |
| Surprise | — | -8.83% | +12.9% | +2.48% |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q1 | May 8, 2026 | $-12.15 | $-36.00 | 66.3 % |
| Q4 | Mar 13, 2026 | $-16.65 | $-40.50 | 58.9 % |
| Q3 | Nov 14, 2025 | $-71.10 | $-40.50 | -75.6 % |
| Q2 | Aug 14, 2025 | $-76.50 | $-45.00 | -70.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q1 | May 8, 2026 | $1.35M | $1.48M | -8.83 % |
| Q4 | Mar 13, 2026 | $1.59M | $1.41M | 12.9 % |
| Q3 | Nov 14, 2025 | $1.45M | $1.41M | 2.48 % |
| Q2 | Aug 14, 2025 | $1.27M | $1.51M | -15.7 % |